AvePoint, Inc.
NASDAQ:AVPTSoftware - Infrastructure
-$0.41 today
- Market cap
- $3.32B
- Beta
- 1.16
- P/E (TTM)
- 47.3
- EPS (TTM)
- $0.22
Volume 2.46M
Average 1.92M
AVPT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AvePoint, Inc.NASDAQ: AVPT
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $16.17M rose 16.0% year over year, ahead of the +13.4% change in trailing-twelve-month research & development. Sequentially, it fell 2.4% from the prior quarter. Over 3 fiscal years it compounded at +18.8% a year.
Context
- Research & development amounted to 12.5% of revenue in FY2025, down 2.2 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +16.0% holds above the trailing-twelve-month pace of +13.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 52.59M USD
- Year-over-year change
- +8.0%
- 4-year CAGR
- +13.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.59M | +8.0% |
| FY2024 | 2024-12-31 | 48.7M | +34.0% |
| FY2023 | 2023-12-31 | 36.34M | +15.9% |
| FY2022 | 2022-12-31 | 31.36M | -1.3% |
| FY2021 | 2021-12-31 | 31.77M | — |
Research & Development vs competitors
How AVPT compares with its peers on the latest reported figures
- AVPT's LTM Sep 2026 research & development of $59.49M is the lowest of the 9 companies compared; the peer median is $258.92M.
- Its year-over-year change of +13.4% is the 3rd highest of 9, against a peer median of +7.5%.
- Research & development amounts to 12.2% of revenue for AVPT, versus a peer median of 21.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $744.6M | -5.3% | -6.4% | 29.4% | |
| LTM Jul 2026 | $651M | +3.5% | +1.0% | 21.2% | |
| LTM Jun 2026 | $463.7M | +12.1% | +9.3% | 16.8% | |
| LTM Sep 2026 | $286.39M | +28.0% | +10.2% | 40.0% | |
| LTM Jul 2026 | $231.45M | +33.4% | +11.8% | 19.9% | |
| LTM Jun 2026 | $223.97M | +9.1% | +15.9% | 21.5% | |
| LTM Mar 2026 | $191.13M | +5.9% | +0.1% | 22.2% | |
| LTM Sep 2026 | $118.88M | +1.9% | +5.0% | 16.5% | |
| LTM Sep 2026 | $59.49M | +13.4% | +18.8% | 12.2% | |
| Peer median (excluding AVPT) | $258.92M | +7.5% | +7.2% | 21.3% | |
Competitors are the stored peer set for AVPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 191.91M | 232.34M | 271.83M | 330.48M | 419.5M |
| Cost of Revenue | 52.66M | 66.28M | 77.46M | 82.53M | 108.8M |
| Gross Profit | 139.25M | 166.06M | 194.37M | 247.96M | 310.7M |
| Gross Margin | 72.6% | 71.5% | 71.5% | 75.0% | 74.1% |
| Research & Development | 31.77M | 31.36M | 36.34M | 48.7M | 52.59M |
| Selling, General & Admin | 159.73M | 175.77M | 173.38M | 192.09M | 225.08M |
| Operating Expenses | 192.74M | 207.13M | 209.72M | 240.79M | 277.66M |
| Depreciation & Amortization | 1.24M | 3.49M | 4.69M | 5.38M | 6.21M |
| EBITDA | (31.55M) | (30.12M) | (13.93M) | (19.02M) | 46.71M |
| EBITDA Margin | -16.4% | -13.0% | -5.1% | -5.8% | 11.1% |
| Operating Income | (53.49M) | (40.37M) | (15.35M) | 7.17M | 33.04M |
| Operating Margin | -27.9% | -17.4% | -5.6% | 2.2% | 7.9% |
| Interest Income | 102K | 0 | 26K | 166K | 4.57M |
| Interest Expense | 0 | 40K | 0 | 0 | 0 |
| Other Income / Expenses | 20.7M | 6.72M | (3.26M) | (31.57M) | 7.47M |
| Income Before Tax | (32.79M) | (33.65M) | (18.61M) | (24.4M) | 40.5M |
| Pre-Tax Margin | -17.1% | -14.5% | -6.8% | -7.4% | 9.7% |
| Income Tax Expense | 457K | 5.04M | 2.89M | 4.74M | 5.38M |
| Net Income | (35.22M) | (41.63M) | (21.73M) | (29.09M) | 35.12M |
| Net Margin | -18.4% | -17.9% | -8.0% | -8.8% | 8.4% |
| EPS (Basic) | (0.48) | (0.23) | (0.12) | (0.16) | 0.17 |
| EPS (Diluted) | (0.48) | (0.23) | (0.12) | (0.16) | 0.15 |
| Weighted Avg Shares | 141.6M | 181.96M | 182.26M | 183.72M | 207.59M |
| Weighted Avg Shares (Diluted) | 141.6M | 181.96M | 182.26M | 183.72M | 229.29M |
AvePoint, Inc.
NASDAQ:AVPT
Intrinsic Alpha fair value
Locked
Current Price
$15.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.